Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Fasenra Approved for Treatment of Children Aged 6 to 11 with Severe Asthma

(BUSINESS WIRE) April 11, 2024 --AstraZeneca’s Fasenra® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on...

Xcopri (cenobamate) Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube

 SK Life Science, Inc., a U.S. pharmaceutical company developing treatments that will change the future of central nervous system (CNS) disorders...

AI Matches Experts in Spotting Radiology Errors

Artificial intelligence can serve as a helpful backup editor to radiologists, making sure their reports are accurate and reliable, a new study says.The...

Melatonin Gummies to Get Safety Labeling, Child-Safe Bottles After Poisonings

In the wake of a sharp rise in the number of young children accidentally eating melatonin supplements, an industry group has called for tougher safety...

CDC Warns of 19 Cases of Botched Botox Shots in 9 States

Counterfeit or mishandled Botox shots have triggered harmful reactions in 19 people in nine states, U.S. health officials warned Monday.In its alert, the...

A More Diverse Nature Brings Better Mental Health

Want to feel happier?Live in or near a place with a rich diversity of nature, a new study says.Environments with plentiful natural features -- trees, birds,...

TLX101-CDx (Pixclara) Granted FDA Fast Track Designation

 Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation1 for the Company’s...

2011 to 2020 Saw Increase in Annual Prescription Meds Expenditures

From 2011 to 2020, there was an increase in total annual prescription medication expenditures, with antimetabolic agents the most costly category, according...

Childhood Cancer Survivors Face Socioeconomic Difficulties

Childhood cancer survivors face socioeconomic difficulties, according to a review published online April 15 in JAMA Pediatrics.Márk Viktor Hernádfői,...

2011 to 2021 Saw Increase in Vaccination Timeliness for Infants

From 2011 to 2021, there was an increase in vaccination timeliness among U.S. children aged 0 to 19 months, according to a study published online April...

In-Hospital Mortality Rare After Percutaneous Coronary Intervention

In-hospital mortality is rare after percutaneous coronary intervention (PCI) and is most commonly related to prior cardiovascular condition, according...

The United States FDA Awards Orphan Drug Designation (ODD) to NM5072 for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)

NovelMed today announced that the Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to NM5072, an Alternative Pathway (AP)...

Tips To Getting Your Rosacea Under Control

Rosacea is a common skin condition that causes redness on a person’s face. It commonly appears as a tendency to blush or flush more easily, but...

Otsuka Initiates Voluntary Nationwide Recall of Certain Lots of Abilify (aripiprazole) Tablets Due to Drug Product Cross-Contamination on Manufacturing Equipment

PRINCETON, N.J. (April 9, 2024) – Otsuka America Pharmaceutical, Inc. (Otsuka) is voluntarily recalling certain Abilify (aripiprazole) Tablets in...

Read more news...

Recently Added

Recently added consumer and prescribing information: Risvan, Voydeya, Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne, Wyost

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Zevtera Zevtera (ceftobiprole medocaril) is a cephalosporin antibiotic for the treatment of bacteremia, acute bacterial skin and skin structure...
  • Risvan Risvan (risperidone) is an atypical antipsychotic indicated for the treatment of schizophrenia in adults.
  • Voydeya Voydeya (danicopan) is a complement factor D inhibitor used for the treatment of extravascular hemolysis in adults with paroxysmal...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development